TY  - GEN
AU  - None
TI  - Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the 
Indonesian healthcare setting
PY  - 2022
PB  - Fakultas Farmasi UGM
UR  - 
ER  -